Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear targetKongfei Li, Hongyan Tong|Journal of Translational Medicine|2014Cited by 48
PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulationChao Hu, Hongyan Tong|Scientific Reports|2017Cited by 22
RIPK3 deficiency blocks R-2-hydroxyglutarate–induced necroptosis in IDH-mutated AML cellsShuanghong Zhu, Hongyan Tong|Science Advances|2024Cited by 19
All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complexLu Wang, Hongyan Tong|British Journal of Cancer|2022Cited by 18